A randomized trial of intensive versus standard blood-pressure control [1]

New England Journal of Medicine

Volumn 374, Issue 23, 2016, Pages 2290-

  Pfeffer, Marc A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; ASYMPTOMATIC DISEASE; BLOOD PRESSURE REGULATION; FUNDING; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; INTERVENTION STUDY; LETTER; MORTALITY RATE; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARD; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; BLOOD PRESSURE; FEMALE; MALE; PRACTICE GUIDELINE;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; MALE; PRACTICE GUIDELINES AS TOPIC;

EID: 84973890999     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1602668     Document Type: Letter

References (2)

1. The SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015;373:2103-16.
2. Ambrosius WT, Sink KM, Foy CG, et al. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT). Clin Trials 2014;11:532-46.